Literature DB >> 8811652

Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

B Wilske1, U Busch, H Eiffert, V Fingerle, H W Pfister, D Rössler, V Preac-Mursic.   

Abstract

Neuroborreliosis is the most frequent manifestation of the second stage of Lyme borreliosis in Europe. However, only few isolates from the cerebrospinal fluid (CSF) have been characterized with controversial results. A large panel of 36 CSF isolates isolated over a 10-year period in Munich has now been analyzed for their OspA and OspC type, resulting in at least eight different types, respectively. Representatives of the different types cultivated from CSF in Munich have also been isolated from other geographical regions in Europe from CSF or ticks, suggesting a widespread distribution of pathogenic strains. A certain OspA type (type 4) was frequently observed in adults but rarely in children or ticks. Since OspA and OspC are the most promising candidates for a Borrelia vaccine, the considerable heterogeneity found among CSF isolates has important implications for development of a vaccine in Europe.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811652     DOI: 10.1007/bf02456135

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  44 in total

1.  Molecular characterization of Borrelia burgdorferi isolated from Ixodes ricinus in northern Sweden.

Authors:  S Bergström; B Olsén; N Burman; L Gothefors; T G Jaenson; M Jonsson; H A Mejlon
Journal:  Scand J Infect Dis       Date:  1992

2.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

Authors:  H Fuchs; R Wallich; M M Simon; M D Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Authors:  B Wilske; V Preac-Mursic; U B Göbel; B Graf; S Jauris; E Soutschek; E Schwab; G Zumstein
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen.

Authors:  M Theisen; B Frederiksen; A M Lebech; J Vuust; K Hansen
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Molecular characterization of Borrelia burgdorferi sensu lato strains by pulsed-field gel electrophoresis.

Authors:  U Busch; C H Teufel; R Boehmer; B Wilske; V Preac-Mursic
Journal:  Electrophoresis       Date:  1995-05       Impact factor: 3.535

7.  Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe.

Authors:  S D Lovrich; S M Callister; L C Lim; B K DuChateau; R F Schell
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

8.  Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients.

Authors:  I Demaerschalck; A Ben Messaoud; M De Kesel; B Hoyois; Y Lobet; P Hoet; G Bigaignon; A Bollen; E Godfroid
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers.

Authors:  J L Coleman; T J Sellati; J E Testa; R R Kew; M B Furie; J L Benach
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

View more
  45 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Lyme disease--current state of knowledge.

Authors:  Roland Nau; Hans-Jürgen Christen; Helmut Eiffert
Journal:  Dtsch Arztebl Int       Date:  2009-01-30       Impact factor: 5.594

3.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Dogs as sentinels for human Lyme borreliosis in The Netherlands.

Authors:  H A Goossens; A E van den Bogaard; M K Nohlmans
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field.

Authors:  C M Hu; B Wilske; V Fingerle; Y Lobet; L Gern
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis.

Authors:  J D Lünemann; S Zarmas; S Priem; J Franz; R Zschenderlein; E Aberer; R Klein; L Schouls; G R Burmester; A Krause
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.

Authors:  Gereon Goettner; Ulrike Schulte-Spechtel; Ruth Hillermann; Gabi Liegl; Bettina Wilske; Volker Fingerle
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis.

Authors:  Ulrike Schulte-Spechtel; Gisela Lehnert; Gaby Liegl; Volker Fingerle; Christiane Heimerl; Barbara J B Johnson; Bettina Wilske
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

9.  Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.

Authors:  Nathalie D van Burgel; Peter Kraiczy; Tim J Schuijt; Peter F Zipfel; Alje P van Dam
Journal:  BMC Microbiol       Date:  2010-02-10       Impact factor: 3.605

Review 10.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.